Nasal nitric oxide levels and nasal polyposis in children and adolescents with cystic fibrosis

JAMA Otolaryngology - Head and Neck Surgery

Volumn 139, Issue 9, 2013, Pages 931-936

  De Winter de Groot, Karin M ^a   Van Haren Noman, Sanne ^a   Speleman, Lucienne ^a   Schilder, Anna G M ^a,b   Van Der Ent, Cornelis K ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE;

ADOLESCENCE; ADOLESCENT; ADULT; AIRWAY; ARTICLE; BACTERIAL COLONIZATION; BODY MASS; CHILD; CROSS-SECTIONAL STUDY; CYSTIC FIBROSIS; ENDOSCOPIC SINUS SURGERY; ENDOSCOPY; EXPIRED AIR; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; FRACTIONAL EXHALED NITRIC OXIDE; GENOTYPE; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; NASAL NITRIC OXIDE; NOSE; NOSE DISEASE; NOSE POLYP; NUTRITIONAL STATUS; PRESCHOOL CHILD; PSEUDOMONAS AERUGINOSA; SCHOOL CHILD; SPUTUM CULTURE; STAPHYLOCOCCUS AUREUS; TERTIARY HEALTH CARE;

ADOLESCENT; ANALYSIS OF VARIANCE; BREATH TESTS; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; CYSTIC FIBROSIS; ENDOSCOPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MULTIVARIATE ANALYSIS; NASAL CAVITY; NASAL POLYPS; NITRIC OXIDE; PROSPECTIVE STUDIES; REFERENCE VALUES; REFERRAL AND CONSULTATION; RESPIRATORY FUNCTION TESTS; RISK ASSESSMENT; TERTIARY CARE CENTERS; TREATMENT OUTCOME;

EID: 84885753178     PISSN: 21686181     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaoto.2013.4099     Document Type: Article

References (31)

1. Barnes PJ, Belvisi MG. Nitric oxide and lung disease. Thorax. 1993;48(10):1034-1043.
2. Lundberg JO, Farkas-Szallasi T, Weitzberg E, et al. High nitric oxide production in human paranasal sinuses. Nat Med. 1995;1(4):370-373.
3. Grasemann H, Ratjen F. Cystic fibrosis lung disease: the role of nitric oxide. Pediatr Pulmonol. 1999;28(6):442-448.
4. Balfour-Lynn IM, Laverty A, Dinwiddie R. Reduced upper airway nitric oxide in cystic fibrosis. Arch Dis Child. 1996;75(4):319-322.
5. Elphick HE, Demoncheaux EA, Ritson S, Higenbottam TW, Everard ML. Exhaled nitric oxide is reduced in infants with cystic fibrosis. Thorax. 2001;56(2):151-152.
6. Struben VMD, Sewbalak WV, Wieringa MH, et al. Nasal nitric oxide in cystic fibrosis with and without humming. Eur J Clin Invest. 2007;37(2):140-144.
7. De Gaudemar I, Contencin P, Van den Abbeele T, Munck A, Navarro J, Narcy P. Is nasal polyposis in cystic fibrosis a direct manifestation of genetic mutation or a complication of chronic infection? Rhinology. 1996;34(4):194-197.
8. Leiberman A, Dagan R, Leibovitz E, Yagupsky P, Fliss DM. The bacteriology of the nasopharynx in childhood. Int J Pediatr Otorhinolaryngol. 1999;49(suppl 1):S151-S153.
9. de Winter-de Groot KM, van der Ent CK. Nitric oxide in cystic fibrosis. J Cyst Fibros. 2005;4(suppl 2):25-29.
10. Feuillet-Fieux MN, Lenoir G, Sermet I, et al. Nasal polyposis and cystic fibrosis(CF): review of the literature. Rhinology. 2011;49(3):347-355.
11. Keen C, Olin AC, Edentoft A, Gronowitz E, Strandvik B. Airway nitric oxide in patients with cystic fibrosis is associated with pancreatic function, Pseudomonas infection, and polyunsaturated fatty acids. Chest. 2007;131(6):1857-1864.
12. Grasemann H, Storm van's Gravesande K, Gärtig S, et al. Nasal nitric oxide levels in cystic fibrosis patients are associated with a neuronal NO synthase (NOS1) gene polymorphism. Nitric Oxide. 2002;6(2):236-241.
13. Zapletal A, Paul T, Samánek M. Normal values of static pulmonary volumes and ventilation in children and adolescents [in Czech]. Cesk Pediatr. 1976;31(10):532-539.
14. Baraldi E, de Jongste JC; European Respiratory Society/American Thoracic Society (ERS/ATS) Task Force. Measurement of exhaled nitric oxide in children, 2001. Eur Respir J. 2002;20(1):223-237.
15. American Thoracic Society; European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005;171(8):912-930.
16. de Winter-de Groot KM, van der Ent CK. Measurement of nasal nitric oxide: evaluation of six different samplingmethods. Eur J Clin Invest. 2009;39(1):72-77.
17. Struben VMD, Wieringa MH, Mantingh CJ, et al. Nasal NO: normal values in children age 6 through to 17 years. Eur Respir J. 2005;26(3):453-457.
18. Colantonio D, Brouillette L, Parikh A, Scadding GK. Paradoxical low nasal nitric oxide in nasal polyposis. Clin Exp Allergy. 2002;32(5):698-701.
19. Deroee AF, Naraghi M, Sontou AF, Ebrahimkhani MR, Dehpour AR. Nitric oxide metabolites as biomarkers for follow-up after chronic rhinosinusitis surgery. Am J Rhinol Allergy. 2009;23(2):159-161.
20. Kirihene RK, Rees G, Wormald PJ. The influence of the size of the maxillary sinus ostium on the nasal and sinus nitric oxide levels. Am J Rhinol. 2002;16(5):261-264.
21. Thomas SR, Kharitonov SA, Scott SF, Hodson ME, Barnes PJ. Nasal and exhaled nitric oxide is reduced in adult patients with cystic fibrosis and does not correlate with cystic fibrosis genotype. Chest. 2000;117(4):1085-1089.
22. Weiglein A, Anderhuber W, Wolf G. Radiologic anatomy of the paranasal sinuses in the child. Surg Radiol Anat. 1992;14(4):335-339.
23. Jones N. The nose and paranasal sinuses physiology and anatomy. Adv Drug Deliv Rev. 2001;51(1-3):5-19.
24. Mancinelli RL, McKay CP. Effects of nitric oxide and nitrogen dioxide on bacterial growth. Appl Environ Microbiol. 1983;46(1):198-202.
25. Kaplan SS, Lancaster JR Jr, Basford RE, Simmons RL. Effect of nitric oxide on staphylococcal killing and interactive effect with superoxide. Infect Immun. 1996;64(1):69-76.
26. Malawista SE, Montgomery RR, van Blaricom G. Evidence for reactive nitrogen intermediates in killing of staphylococci by human neutrophil cytoplasts: a new microbicidal pathway for polymorphonuclear leukocytes. J Clin Invest. 1992;90(2):631-636.
27. Haubitz M, Busch T, Gerlach M, et al. Exhaled nitric oxide in patients with Wegener's granulomatosis. Eur Respir J. 1999;14(1):113-117.
28. Kempainen RR, Sajan JA, Pylkas AM, Dunitz JM, Rimell FL, Milla CE. Effect of endoscopic sinus surgery on pulmonary status of adults with cystic fibrosis. Otolaryngol Head Neck Surg. 2012;147(3):557-562.
29. Osborn AJ, Leung R, Ratjen F, James AL. Effect of endoscopic sinus surgery on pulmonary function and microbial pathogens in a pediatric population with cystic fibrosis. Arch Otolaryngol Head Neck Surg. 2011;137(6):542-547.
30. Franklin PJ, Hall GL, Moeller A, Horak F Jr, Brennan S, Stick SM. Exhaled nitric oxide is not reduced in infants with cystic fibrosis. Eur Respir J. 2006;27(2):350-353.
31. Zhang Y, Endam LM, Filali-Mouhim A, Bossé Y, Castano R, Desrosiers M. Polymorphisms in the nitric oxide synthase 1 gene are associated with severe chronic rhinosinusitis. Am J Rhinol Allergy. 2011;25(2):e49-e54.